Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

Details for Australian Patent Application No. 2008282130 (hide)

Owner Accera, Inc.

Inventors Henderson, Samuel T.

Agent Davies Collison Cave

Pub. Number AU-A-2008282130

PCT Pub. Number WO2009/018478

Priority 60/953,074 31.07.07 US

Filing date 31 July 2008

Wipo publication date 5 February 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 31/12 (2006.01) - Ketones

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/018478 Priority application(s): WO2009/018478

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008282147-Ultrasonic surgical instruments

2008282118-Naphthyridine derivatives as potassium channel modulators